Company · founded 1969

Leidos (United States)

Reston, United States · leidos.com

Manage this page

Citations, last 5 years: 6 675
Works, last 5 years: 1 109
h-index: 290
Scientists listed: 163
Grants since 2016: 653

Grants received

2019–2027 · contract · N01

NEURESTA DRUG SUBSTANCE MANUFACTURING

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$1 363

2019–2024 · contract · N02

FFRDC TASK ORDER - LEASES

Beverly Hayes · Leidos (United States) · funded by National Institutes of Health

$18.7M

2019–2020 · contract · N01

DCP- Cancer Immunoprevention Laboratory Support

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$2.2M

2019–2020 · contract · N01

DCP - Cancer Prevention Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia) BioRepository

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$39.9k

2019–2020 · contract · N01

HPV Serology

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$874.3k

2019–2023 · contract · N01

NCI Moonshot: NCI-DOE Collaboration

Leonard Freedman · Leidos (United States) · funded by National Institutes of Health

$4.5M

2019–2020 · contract · N01

TAS::75 0849::TAS INCREMENTAL FUNDING

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$170.5k

2019–2023 · contract · N01

NCI Moonshot: Accelerate Cervical Cancer Control

Leonard Freedman · Leidos (United States) · funded by National Institutes of Health

$514.4kCervical Cancer and HPV Research

2019–2027 · contract · N01

NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents

Christopher Case · Leidos (United States) · funded by National Institutes of Health

$2.2M

2019–2020 · contract · N01

Genotyping for epidemiology studies

Ethan Dmitrovsky · Leidos (United States) · funded by National Institutes of Health

$565.3k

2019–2024 · contract · N01

GD2 CAR T MANUFACTURING

George Mitra · Leidos (United States) · funded by National Institutes of Health

$4.7M

2019–2020 · contract · N01

Molecular Pharmacology Lab

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$538.5k

2019–2023 · contract · N01

NCI Moonshot: NCI-DOE Collaboration

Leonard Freedman · Leidos (United States) · funded by National Institutes of Health

$3M

2019–2020 · contract · N01

VENTANA PD-L1 (SP142), a complimentary diagnostic immunohistochemistry (IHC) assay to ascertain tumor PD-L1 status for patients with metastatic urothelial cancer considering treatment with atezolizuma

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$100k

2019–2024 · contract · N02

NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT - FY19 FACILITIES TO A

Keith Leaman · Leidos (United States) · funded by National Institutes of Health

$41.4k

2019–2020 · contract · N01

DCEG- Molecular Assays for epidemiology studies

Ethan Dmitrovsky · Leidos (United States) · funded by National Institutes of Health

$321.2k

2019–2026 · contract · N01

NCI Moonshot: Accelerate Cervical Cancer Control

Leonard Freedman · Leidos (United States) · funded by National Institutes of Health

$3MCervical Cancer and HPV Research

2019–2020 · contract · N02

EXPAND LN2 PIPING DISTRIBUTION, WEDGEWOOD SUITE K

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$301.2k

2019–2020 · contract · N01

Eye Exams Associated with Anetumab Ravtansine Administration

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$32k

2019–2020 · contract · N01

DCP Support- HPV16L1/RG1 Virus-Like Particle Vaccine

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$322k

2019–2020 · contract · N01

DCEG- GWAS Studies

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$7.2M

2019–2023 · contract · N01

NCI Moonshot: NCI-DOE Collaboration

Leonard Freedman · Leidos (United States) · funded by National Institutes of Health

$3.3M

2019–2020 · contract · N01

DCP - Support to NSRG

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$60k

2019–2020 · contract · N01

TCGA CLinical Data Update

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$1.4M

2019–2024 · contract · N02

NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT - FY19 FACILITIES TO A

Keith Leaman · Leidos (United States) · funded by National Institutes of Health

$61.4k

2019–2020 · contract · N01

Informatics Support at FNLCR

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$35.8M

2019–2020 · contract · N01

Repository for the Family Investigation of Nephropathy & Diabetes

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$31.6k

2019–2020 · contract · N01

DCCPS- Surveillance Research Program

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$418.6k

2019–2020 · contract · N01

Cryo-EM

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$540.6k

2019–2026 · contract · N01

CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS

George Mitra · Leidos (United States) · funded by National Institutes of Health

$1.8M

2019–2020 · contract · N01

Division of Cancer Tratment and DIagnosis- Operational Task Order

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$8.7M

2019–2020 · contract · N01

BLGSP Continuation

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$821.3k

2019–2020 · contract · N01

Biospecimen Collection Proteomic

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$5.5M

2019–2020 · contract · N01

NCI-F Operations and Technical Support II

Leonard Freedmand · Leidos (United States) · funded by National Institutes of Health

$1.3M

2019–2020 · contract · N01

GWAS Studies

Ethan Dmitrovsky · Leidos (United States) · funded by National Institutes of Health

$901.9k

2019–2026 · contract · N01

NCI Moonshot: Accelerate Cervical Cancer Control

Leonard Freedman · Leidos (United States) · funded by National Institutes of Health

$972.6k

2019–2027 · contract · N01

CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS

George Mitra · Leidos (United States) · funded by National Institutes of Health

$4.5M

2019–2028 · contract · N01

MD NET

Ralph Parchment · Leidos (United States) · funded by National Institutes of Health

$42M

2018–2020 · contract · N01

HHSN261201500003I; HHSN26100082; 400.001.0082.0001; NCI OD-Frederick; Appropriated; RI; 125218 Exterior Ladders - Phase 2 -Buildings 434, 550, 560, 567; 09/24/2018 06/23/2020

Bart Christy · Leidos (United States) · funded by National Institutes of Health

$1.8M

2018–2023 · contract · N01

HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23

Dwayne Forquer · Leidos (United States) · funded by National Institutes of Health

$10.5M